Experts

Vaccine and Parenteral Manufacturing

Dr. Gerson is principle of Axenic, Inc., a global consulting firm specializing in process development, manufacturing, facility design and cGMP operations for the biopharmaceutical industries. He has worked as managing director for manufacturing and development at the International AIDS Vaccine Initiative, VP of manufacturing and development at Acambis, where he developed the process for and manufactured over 200 million doses of Smallpox vaccine. Prior to that, he worked as managing director of vaccine manufacturing at Wyeth-Lederle Vaccines, and before that, as VP of R&D at Apotex Fermentation, Inc., and as Assostant VP of manufacturing and process development for Connaught Laboratories in Toronto.

He has a Ph.D. in Biophysics from McGill University, has taught at the University of Western Ontario, and worked as an independent researcher at the Basel Institute for Immunology.

Encouraging new syringe designs internationally
What’s being done to encourage new types of syringe designs internationally?
Category: Vaccine and Parenteral Manufacturing

Challenge of bringing new syringe technologies to market
There are lots of new syringes and injection devices available to manufacturers. What’s keeping them from being brought to market?
Category: Vaccine and Parenteral Manufacturing